Efficacy of lithium treatment in Kleine-Levin syndrome

Eur Psychiatry. 2002 Jul;17(4):232-3. doi: 10.1016/s0924-9338(02)00661-2.

Abstract

The Kleine-Levin syndrome (KLS) is characterized by periodic, sudden-onset episodes of hypersomnia, compulsive hyperphagia, and behavioral-emotional symptoms, lasting from a few days to a few weeks, with complete remission in the intercritical periods. We report on efficacy of lithium treatment in a highly recurring form of the disorder in a 17-year-old male adolescent. The decreasing severity of the disorder paralleled the progressive increase of lithium dosage, up to 0.9 mEq l(-1). Implications regarding the pharmacological treatment of this neglected disorder are discussed.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antimanic Agents / therapeutic use*
  • Compulsive Behavior / complications*
  • Compulsive Behavior / drug therapy*
  • Disorders of Excessive Somnolence / complications*
  • Disorders of Excessive Somnolence / drug therapy*
  • Humans
  • Hyperphagia / complications*
  • Hyperphagia / drug therapy*
  • Lithium Carbonate / therapeutic use*
  • Male
  • Mental Disorders / complications*
  • Mental Disorders / drug therapy*
  • Syndrome

Substances

  • Antimanic Agents
  • Lithium Carbonate